Company news

Adagene, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

April 2, 2026

Decks